ShareSoc, in collaboration with InvestorHub, presents a webinar series designed to spotlight small and midcap companies listed on AIM or the Aquis Exchange, with the aim of providing insights into innovative and high growth prospects within the market.Let's hope they generate some interest. And a corresponding share price rise. |
Discovery Company Webinar – 25 February, 5pm
ShareSoc, in collaboration with InvestorHub, presents the next Discovery Company Webinar, featuring:
* N4 Pharma PLC (N4P)
* SEEEN plc (SEEN)
Hear from the CEOs of both companies as they provide insights into their current progress and future plans.
Register here: |
I guess the share price will drift until the next news. |
Just added. Not showing yet. |
I've not heard the phrase:Shake the tree!for ages. |
POTENTIAL! |
Orphan drug status maybe end Feb beginning March? Fingers crossed. |
Market value from 2m to 2b!Now that would be fantastic. |
Hope there are some good answers tomorrow. |
Adding but shown as sell. |
Hi volume today.I wonder what interest next week's webinar will bring. |
And not surprised if it isn't. :) |
I'll be surprised if this isn't blue today. |
Investor meet company event in Feb |
News please. |
Is this due sometime soon? Nanogenics has now submitted an application to the U.S. Food and Drug Administration ("FDA") to obtain orphan drug designation for its product ECP105, for the prevention of scarring following glaucoma surgery. |
They certainly talking a good talk , maybe finally with some justification, but as Dr Smith says they have to back it up with something more solid to be taken seriously by the market.i.e income no more dilution |
Volumes high. I'm sure there's some FOMO before the announcement of the start of clinical trials. Final results I think are due around 22nd April. |
Does anyone know how long approval is expected to take?· The Company is awaiting ethics committee approval to build on these excellent in vitro data and begin an in vivo study in an appropriate animal model early in 2025 at the University of Queensland. |
Volume high already. What's up?Pump and dump or realisation of the potential?Not sure a placing is coming. All IMHO |
..a placing? |
Are people starting to realise what this will do once trials are announced? |
Come on N4P! |
It just needs an announcement of when trials are starting and, IMHO, this should take off. |
From todays RN:"I believe that Nuvec® will allow the Company to build a differentiated drug pipeline to drive long-term value and generate commercial progress through platform licensing deals and partnerships in the near term." |
Register for streaming realtime charts, analysis tools, and prices.
Hot Features
Premium
